ALVAC-CEA vaccine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by SporkBot (talk | contribs) at 05:44, 18 December 2014 (Repair duplicate template args). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.

A phase I trial in 118 patients showed safety in humans.[1]

References

  1. ^ "Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer". 2008.

External links

Public Domain This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.